Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-03-01 @ 1:44 PM
Study NCT ID:
NCT01910259
Status:
COMPLETED
Last Update Posted:
2020-03-26
First Post:
2013-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
Sponsor:
University College, London
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Secondary Progressive Multiple Sclerosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Secondary Progressive Multiple Sclerosis | View |
| None | Neuroprotective | View |
| None | Repurposed drugs | View |
| None | Brain atrophy | View |
| None | Percentage Brain Volume Change | View |
| None | Magnetic Resonance Imaging | View |
| None | Optical Coherence Tomography | View |
| None | Cerebrospinal fluid | View |
| None | Amiloride | View |
| None | Riluzole | View |
| None | Double blind | View |
| None | Placebo | View |
| None | Fluoxetine | View |